A Long-Term Perspective on the Protective Effects of an Early Invasive Strategy in Unstable Coronary Artery Disease: 15-Year Follow-Up of the FRISC-II Invasive Study

Aug 30, 2016   |  Anthony A. Bavry, MD,MPH,FACC

Clinical Trial

The goal of the FRISC-II study was to evaluate treatment with an early invasive strategy compared with a conservative management strategy on late clinical events.

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Cardiac Surgery, Cardiovascular Care Team, Invasive Cardiovascular Angiography and Intervention, Atherosclerotic Disease (CAD/PAD), Anticoagulation Management and ACS, Interventions and ACS, Interventions and Coronary Artery Disease, Interventions and Imaging, Angiography, Nuclear Imaging

Keywords: Acute Coronary Syndrome, Angina, Unstable, Angiography, Coronary Artery Disease, Creatine Kinase, Dalteparin, Electrocardiography, Exercise Test, Myocardial Infarction, Myocardial Revascularization, Troponin T, ESC Congress

The Role of Biomarkers in Atrial Fibrillation

Sep 10, 2013   |  Ziad Hijazi, MD, PhD; Lars Wallentin, MD

Expert Analysis

Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with an increased risk of stroke and cardiovascular mortality.1,2 The prevalence of AF increases with age and reaches approximately 10% in persons ≥80 years....

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias

Keywords: Anticoagulants, Arrhythmias, Cardiac, Atrial Fibrillation, Risk, Stroke